Taro Pharmaceutical Industries Ltd (NYSE:TARO)

37.19
BATS BZX Real-Time Price
As of May 13
 +0.03 / +0.08%
Today’s Change
35.80
Today|||52-Week Range
76.00
-25.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.5B

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay Haifa 2624761
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Other institutional6.78%
Mutual fund holders5.30%
Individual stakeholders12.06%

Top Executives

Uday Vijaykumar BaldotaChief Executive Officer & Director
Itamar KarsentiVice President & Head-Operations
William J. CooteVP, Chief Financial & Accounting Officer
Avi AvramoffVice President & Head-Research & Development
Richard GlazeVice President & Head-Information Technology